HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

L G Boros Selected Research

Pentoses

12/2004Metabolic sensitivity of pancreatic tumour cell apoptosis to glycogen phosphorylase inhibitor treatment.
10/2001Gleevec (STI571) influences metabolic enzyme activities and glucose carbon flow toward nucleic acid and fatty acid synthesis in myeloid tumor cells.
1/2001Genistein inhibits nonoxidative ribose synthesis in MIA pancreatic adenocarcinoma cells: a new mechanism of controlling tumor growth.
5/2000Population thiamine status and varying cancer rates between western, Asian and African countries.
3/2000Transforming growth factor beta2 promotes glucose carbon incorporation into nucleic acid ribose through the nonoxidative pentose cycle in lung epithelial carcinoma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


L G Boros Research Topics

Disease

10Neoplasms (Cancer)
10/2013 - 01/2000
3Adenocarcinoma
12/2004 - 01/2001
2Leukemia
10/2001 - 01/2001
2Carcinoma (Carcinomatosis)
10/2001 - 03/2000
1Prostatic Neoplasms (Prostate Cancer)
10/2013
1Pancreatic Neoplasms (Pancreatic Cancer)
12/2004
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
10/2001
1Myeloid Leukemia (Leukemia, Myelocytic)
10/2001
1Thiamine Deficiency
08/2001
1Ascites
08/2001
1Hypoxia (Hypoxemia)
03/2000

Drug/Important Bio-Agent (IBA)

8Nucleic AcidsIBA
01/2007 - 01/2000
7Glucose (Dextrose)FDA LinkGeneric
10/2013 - 03/2000
5EnzymesIBA
01/2007 - 01/2000
5PentosesIBA
12/2004 - 03/2000
5CarbonIBA
12/2004 - 03/2000
5Ribose (D-Ribose)IBA
08/2001 - 01/2000
4Fatty Acids (Saturated Fatty Acids)IBA
10/2013 - 08/2001
3IsotopesIBA
12/2004 - 01/2001
3Thiamine (Aneurin)FDA Link
08/2001 - 01/2000
3TransketolaseIBA
08/2001 - 01/2000
2PhytochemicalsIBA
01/2007 - 01/2001
2Imatinib Mesylate (Gleevec)FDA Link
01/2007 - 10/2001
2RNA (Ribonucleic Acid)IBA
12/2004 - 08/2001
2DNA (Deoxyribonucleic Acid)IBA
12/2004 - 08/2001
2Transforming Growth Factor beta (TGF-beta)IBA
10/2001 - 03/2000
1PurinesIBA
10/2013
1Serine (L-Serine)FDA Link
10/2013
1Adenosine Triphosphate (ATP)IBA
10/2013
1Adenylate KinaseIBA
10/2013
1purineIBA
10/2013
1Folic Acid (Vitamin M)FDA LinkGeneric
10/2013
1Folic Acid AntagonistsIBA
10/2013
1Glycine (Aminoacetic Acid)FDA LinkGeneric
10/2013
1Methotrexate (Mexate)FDA LinkGeneric
10/2013
1NADP (NADPH)IBA
10/2013
1RibonucleotidesIBA
10/2013
1CP 320626IBA
12/2004
1Pharmaceutical PreparationsIBA
12/2004
1Glycogen Phosphorylase (Phosphorylase, Glycogen)IBA
12/2004
1GlycogenIBA
12/2004
1Protein Kinase InhibitorsIBA
10/2001
1Enzyme Inhibitors (Inhibitors, Enzyme)IBA
10/2001
1Proteins (Proteins, Gene)FDA Link
10/2001
1HexokinaseIBA
10/2001
1bcr-abl Fusion ProteinsIBA
10/2001
1Glucose-6-PhosphateIBA
10/2001
1PesticidesIBA
10/2001
1isofenphosIBA
10/2001
1Amino AcidsFDA Link
10/2001
1LipidsIBA
10/2001
1OrganophosphatesIBA
10/2001
1quinone (benzoquinone)IBA
08/2001
1Coenzymes (Enzyme Cofactors)IBA
08/2001
1Biological ProductsIBA
08/2001
1AvemarIBA
08/2001
1OxythiamineIBA
08/2001
1GenisteinIBA
01/2001
1VitaminsIBA
05/2000
1thiaminase II (thiaminase)IBA
05/2000
1Transforming Growth Factor beta2IBA
03/2000

Therapy/Procedure

2Drug Therapy (Chemotherapy)
01/2001 - 01/2000
1Therapeutics
01/2007
1Nutritional Support (Artificial Feeding)
08/2001